Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Maimai’s Pathology Weekly Reading Notes Issue 36 | Immunohistochemical Markers for Diagnosing Lipomatous Tumors, Peripheral Nerve Tumors, and Nerve Sheath Tumors

Continue reading
06 2 月

Combined Diagnosis of Ovarian Mucinous Tumors Using EMA, MUC5AC, and Pax-8

Continue reading
06 2 月

Diagnostic Pitfalls: Plasmacytoid Urothelial Carcinoma

Continue reading
06 2 月

Maixin Selected for Fujian Province’s 2016 List of Leading Small Giant Technology Enterprises for Cultivation

Continue reading
06 2 月

Application of Combined Immunohistochemical Markers Cytokeratin7, Cytokeratin20, and Villin in Determining the Primary Site of Metastatic Carcinoma (2)

Continue reading
06 2 月

Spring Blossoms Welcome National Pathology Colleagues to Visit Maixin

Continue reading
06 2 月

Immunohistochemical Differential Diagnosis Chart for Meningioma

Continue reading
06 2 月

MaiXin Expresses Deep Condolences to Martyrs and Deceased Compatriots Who Sacrificed in the Fight Against COVID-19

Continue reading
06 2 月

SF-1: A Diagnostic Tool for Sex Cord-Stromal Tumors

Continue reading
06 2 月

First “Maxxin Cup” Outstanding Case Collection Campaign Awaits Your Participation!

Continue reading
  • «
  • ‹
  • 46
  • 47
  • 48
  • 49
  • 50
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar